Seventure Partners: A Major Pharmaceutical Company Participates as Strategic Investor in Health for Life Capital™ the First Investment Vehicle Focused on the Microbiome Health and Nutrition Revolutionary Sector
14.12.2015 14:44 | Business Wire
Seventure Partners, a European leader in financing innovation, today announced the completion of a new closing for Health for Life Capital ™, the first investment vehicle in the world to anticipate the microbiome revolution in the fields of health and nutrition, with Novartis Pharma AG agreeing to participate. This closing will increase the total amount of funds available to €160Mio.
Since the launch of Health for Life Capital™ in December of 2013, Seventure Partners has proven its strategic vision by anticipating the microbiome revolution in the health and nutrition sectors. Around this vision, Seventure Partners has successfully attracted financial investors, strategic industrialists and entrepreneurs. As a result, Health for Life Capital™ has become a reference in its field.
Health for Life Capital ™ has invested in a unique and specific portfolio of pioneering companies in the field of the microbiome and nutrition, such as the highly promising Enterome, LNC, Maat pharma, Eligo bioscience, Targedys, Micropharma and others
“Seventure Partners believes that large worldwide pharmaceutical groups are increasingly interested in the microbiome field in anticipation of finding new ways to conduct research and developing drugs with accompanying diagnostics; especially for infectious and gastrointestinal diseases, and other indications, as well as immuno-oncology approaches” said Isabelle de Cremoux, CEO and Managing Partner of Seventure.
Continuing, "The very rapid progression of microbiome research gives some answers to the growing problem of chronic inflammatory diseases, addressing their treatment and prevention and sustainably influencing the pharmaceutical, food and diagnostic industries. It will also impact the entire chain of stakeholders in the health field (public authorities, insurance, etc.). This explains why we wanted to unite specific strategic players from all areas as investors in Health for Life Capital™. The microbiome revolution will have an impact in the veterinary and agricultural fields as well as in human healthcare. Current and future research advancements will have a human, social and economic impact worldwide Since the biotechnology sector started in the 1980s, we are now witnessing the emergence of a new sector that will be as important as genomics.”
Health for Life Capital™ relies on a wide network of industrial partners (Danone, Tereos, Lesaffre, Bel, Tornier and now Novartis Pharma) and experts such as INRA (Institut National de Recherche Agronomique), the Danish Technology Institute (DTI), and Chalmers University of Technology in Gothenburg.
The MultiCap Growth funds, managed by Bpifrance Investment under the PIA (program of investments for the future), has also invested in Health for Life Capital TM .
Legal note: The Health for Life Capital investment vehicle is composed of a Luxembourg SICAR and a French FPCI (AIF fund). Seventure Partners acts as an Investment Advisor of the SICAR (Health for Life Management) General Partner, and as the Management Company of the FPCI. This Information is only intended for professional investors. Health for Life Capital™ bears a high risk. Investors could lose all of their investment.
Notes to Editors
About the Human Microbiome: The Human intestinal microbiota is a complex personal ecosystem, usually stable, tightly adapted to the human host and in constant symbiotic interaction with his cells and organs. There are nevertheless numerous conditions and clinical practices that impose stress to the balanced microbiota. The word microbiota represents an ensemble of microorganisms that resides in a previously established environment. The gut microbiota (formerly called gut flora) is the name given today to the microbe population living in human beings intestine. It contains tens of trillions of microorganisms, including at least 1000 different species of known bacteria with more than 3 million genes (150 times more than human genes). Microbiota can, in total, weigh up to 2 kg. One third of the human gut microbiota is common to most people, while two thirds are specific to each person. The microbiota fulfils physiological functions that have a direct impact on health:
• It helps the body to digest certain foods that the stomach and small intestine have not been able to digest.
• It helps with the production of some vitamins (B and K).
• It helps to combat aggressions from other microorganisms, maintaining the wholeness of the intestinal mucosa.
• It plays an important role in the immune system, performing a barrier effect.
• A healthy and balanced gut microbiota is key to ensuring proper digestive functioning.
About Seventure Partners
Seventure Partners is a leading venture capital firm in Europe. Since 1997, Seventure has invested in innovative businesses with high growth potential in digital technologies in France and Germany and in the life sciences field across Europe and North America, with currently over €500m in assets under management as of the end of 2014.
In life sciences, the four areas of focus include biotechnology and pharmaceuticals, connected health and medtech, industrial biotechnology and cleantech, and last but not least: the microbiome, nutrition, personalized medicine and food. Seventure Partners also considers investments in the field of diagnostics, biomarkers, drug delivery systems, lifestyle healthcare and services.
Investments can range between €500k and €10m per round, or up to €20m per company, from early to late stage. In December 2013, Seventure Partners successfully launched its Health for Life Capital™ which has attracted strategic investments from prestigious organizations including Danone, Tereos, Tornier, Lesaffre, Bel and Novartis as well as entrepreneurs and financial institutions.
Seventure is a subsidiary of Natixis Global Asset Management. Natixis is the corporate investment management and financial services arm of Groupe BPCE, the second-largest French bank.
For more details: www.seventure.fr
At the Company
Isabelle de Cremoux
Président du directoire, CEO and managing partner
Tél : + 33 1 58 19 22 72
Email : firstname.lastname@example.org
Tél : +33 1 53 63 27 35
Email : email@example.com
Sue Charles/ Gemma Howe
Tel: +44 20 7866 7860
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Publication of Clinical Data Demonstrating Low Immunogenicity and Excellent Efficacy of Nuwiq® in Previously Untreated Patients23.8.2017 06:00 | Pressemelding
Octapharma is delighted to announce the publication of interim data from the NuProtect study (GENA-05, NCT01712438), the first clinical data on treatment with Nuwiq® in previously untreated patients (PUPs), on August 16th 2017 as an Early View article in the internationally renowned medical journal Haemophilia. The NuProtect study was initiated in March 2013 to investigate the immunogenicity, efficacy and safety of Nuwiq® in PUPs with severe haemophilia A, who are at the greatest risk of developing inhibitors. The ongoing study has enrolled 110 PUPs of any age or ethnicity who will receive Nuwiq® for up to 100 exposure days (EDs), making it one of the largest studies with a single FVIII product. Patients who previously received any FVIII concentrates or blood products containing FVIII are excluded from the study. The recently published article describes interim results for 6
IBC’s Big Screen to Explore the Future of Camera and Display Technologies and the Business Behind Cinema22.8.2017 16:58 | Pressemelding
IBC today announced the details of its Big Screen programme, taking place in a specially built auditorium designed to IBC’s specifications and featuring the very latest in cinema technology. With the latest Dolby Vision dramatic imaging and Dolby Atmos immersive audio sound installation, the four-day programme examines and demonstrates the hottest topics, themes, and insights surrounding the art, science, and business of cinema - from capture through to exhibition. As well as being the home of the Big Screen programme, the auditorium will screen in Dolby Vision and Dolby Atmos, Baby Driver, the acclaimed Edgar Wright feature from 2017. The programme for 2017, which has been shaped by a committee of global industry professionals, is an insightful examination of the future of cinema. From virtual reality in cinema to laser and camera assessments, visitors will get up to speed
Digi Communications N.V. Announces the Publishing of an Update to the Investigation by the Romanian National Anti-Corruption Directorate22.8.2017 16:38 | Pressemelding
In connection with the investigation triggered by the Romanian National Anti-Corruption Directorate (“DNA”), which we have previously disclosed to the market and to our investors in the initial public offering prospectus dated 26 April 2017, in the supplemental prospectus dated 8 May 2017 (together, the “Prospectus”), as well as in the subsequent public reports, we inform you that, based on the public release no 832/VIII/3 issued on 22 August 2017, the DNA sent to court under the judiciary control Mr. Ioan Bendei (Vice-president of the Board of Directors of RCS & RDS S.A. – the Company’s subsidiary („RCS&RDS”)) in connection with the offences of bribery and accessory to money laundering, as well as RCS&RDS in connection with the offences of bribery and money laundering, INTEGRASOFT S.R.L. (one of RCS&RDS’s subsidiaries in Romania) in connection with the offence of accessory to mon
SailPoint Named a Leader in Cloud-based Identity Governance22.8.2017 14:00 | Pressemelding
SailPoint, the leader in enterprise identity management, was recently named the overall market leader in KuppingerCole’s 2017 “Leadership Compass: Identity as a Service: Cloud-based Provisioning, Access Governance and Federation.” In addition to being named a leader in every category of the report, SailPoint received superior rankings in four of the five evaluation criteria: security, functionality, interoperability and usability. KuppingerCole is an international and independent analyst organization with a strong focus on Information Security and Identity and Access Management. KuppingerCole’s Leadership Compass reports provide an in-depth analysis of the main players in the market, defining each as a follower, challenger or leader. The Leadership Compass Report for IDaaS evaluates leaders in innovation, product features, and market reach for identity-as-a-service offerings tar
Meggitt Training Systems to Exhibit at DSEI 201722.8.2017 14:00 | Pressemelding
Meggitt Training Systems, the leading provider of integrated live-fire and virtual weapons training products and services for armed forces and law enforcement, will participate at Defence and Security Equipment International (DSEI) through the Georgia Department of Economic Development. The military and security industry event will be held September 12-15, 2017 at ExCeL in London, England. “Today’s threats necessitate maximum realism, despite stretched budgets, and that’s what Meggitt provides to government and commercial customers globally,” said Mark Mears, managing director at Meggitt Training Systems, Ltd. “Although proudly based in Georgia, Meggitt Training Systems is part of Meggitt PLC, a UK-headquartered corporation. As such, we particularly look forward to engaging with current and prospective customers at DSEI, the UK’s largest defense and security trade show.” On
Camelbay Real Estate Management NL B.V. Selects Yardi Voyager22.8.2017 13:58 | Pressemelding
Camelbay Real Estate Management NL B.V. will utilise Yardi Voyager® 7S, a browser-agnostic, fully mobile Software-as-a-Service platform, as its accounting and property management platform. Camelbay will use Yardi Voyager to streamline its property management, leasing and accounting processes for its Dutch real estate portfolio, which is predominantly comprised of commercial office assets. “The automation, transparency and fully integrated accounting and property management that Voyager provides will help us manage our daily financial and operational activities more efficiently and enhance our competitive position within the Dutch office market,” said Alon Levy, Director of Camelbay Real Estate Management NL B.V. “We are very pleased to welcome Camelbay as our latest client in the Netherlands,” said Neal Gemassmer, Vice President of International for Yardi.
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom